iBio director granted 60,000 stock options
iBio, Inc. director Elizabeth Stoner received a grant of stock options covering 60,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
iBio, Inc. director Elizabeth Stoner received a grant of stock options covering 60,000 shares of common stock. The options have an exercise price of 1.42 per share and expire on 2036-05-17. They vest monthly on a pro rata basis over 36 months, and following this award she holds 60,000 options in total.
Insider Trade Summary
Grant/Award: 60,000 shares
Grant/Award
1 txn
Insider
Stoner Elizabeth
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 60,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 60,000 contracts (Direct)
Footnotes (1)
- F1. Vesting monthly on a pro rata basis over 36 months.
Key Figures
Options granted: 60,000 options
Exercise price: 1.42 per share
Underlying shares: 60,000 shares
+3 more
6 metrics
Options granted
60,000 options
Stock Option (right to buy) granted to director
Exercise price
1.42 per share
Exercise price for the stock option grant
Underlying shares
60,000 shares
Common stock underlying the option
Expiration date
2036-05-17
Option expiration for this grant
Vesting period
36 months
Vests monthly on a pro rata basis
Options after transaction
60,000 options
Total derivative securities following the grant
Key Terms
Stock Option (right to buy), derivative, exercise price, vesting monthly, +1 more
5 terms
Stock Option (right to buy) financial
"security title is listed as Stock Option (right to buy)"
derivative financial
"transaction type is classified as derivative"
A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.
exercise price financial
"conversion or exercise price is reported as 1.4200"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting monthly financial
"footnote states Vesting monthly on a pro rata basis over 36 months"
expiration date financial
"expiration date is disclosed as 2036-05-17"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did iBio (IBIO) director Elizabeth Stoner report on this Form 4?
Elizabeth Stoner reported receiving a stock option grant for 60,000 shares of iBio common stock. The award is a compensation-related grant, not an open-market stock purchase or sale, and is reflected as a derivative security position.
What are the key terms of Elizabeth Stoner’s iBio stock option grant?
The option covers 60,000 underlying shares of iBio common stock with an exercise price of 1.42 per share. It is structured as a derivative security granting the right to buy shares at this fixed exercise price in the future.
How do the iBio stock options granted to Elizabeth Stoner vest?
The stock options vest monthly on a pro rata basis over 36 months. This means a portion of the 60,000 options becomes exercisable each month during the three-year vesting period, rather than all vesting at once on a single date.
When do Elizabeth Stoner’s iBio stock options expire?
The options expire on 2036-05-17, giving a long exercise window. After that expiration date, any unexercised options will lapse and no longer provide the right to buy iBio common stock at the 1.42 exercise price.
How many iBio options does Elizabeth Stoner hold after this transaction?
Following this grant, Elizabeth Stoner holds 60,000 stock options in total. The Form 4 shows total derivative securities following the transaction equal to 60,000, indicating this award establishes her reported option position at that level.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates